Literature DB >> 22800977

Malignant liver tumors.

Joshua N Honeyman1, Michael P La Quaglia.   

Abstract

Malignant tumors of the liver comprise a relatively small fraction of the total number of pediatric malignancies. However, these tumors can be a significant cause of morbidity and mortality, and there have been significant therapeutic gains during the past few decades through advances in systemic therapy and surgical treatment. Even in patients with advanced local disease, complete resection is now a possibility because of improvements in liver transplantation techniques. In this review, we will discuss the staging and treatment of common malignant tumors of the liver.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22800977     DOI: 10.1053/j.sempedsurg.2012.05.007

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  6 in total

1.  Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.

Authors:  Yesenia Rojas; R Paul Guillerman; Wei Zhang; Sanjeev A Vasudevan; Jed G Nuchtern; Patrick A Thompson
Journal:  Pediatr Radiol       Date:  2014-05-18

2.  Morbidity and mortality associated with liver resections for primary malignancies in children.

Authors:  Nathan P Zwintscher; Kenneth S Azarow; John D Horton
Journal:  Pediatr Surg Int       Date:  2014-03-20       Impact factor: 1.827

3.  Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.

Authors:  Wei Zhao; Juan Li; Junjie Zhang; Pengfei Gao; Hang Pei; Lei Wang; Fei Guo; Jiekai Yu; Shu Zheng; Jiaxiang Wang
Journal:  Int J Mol Sci       Date:  2015-06-04       Impact factor: 5.923

4.  A single-center retrospective study of pediatric hepatoblastoma.

Authors:  Yi Zhang; Weiling Zhang; Suoqin Tang; Liping Chen; You Yi; Pinwei Zhang; Aiping Liu; Tian Zhi; Dongsheng Huang
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

5.  Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients.

Authors:  BinBin Zhang; GongBao Liu; XiangQi Liu; Shan Zheng; Kuiran Dong; Rui Dong
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Treatment outcomes for hepatoblastoma children with pulmonary metastasis and extrapulmonary involvement: experience of 36 cases at a single institution.

Authors:  Hui-Min Hu; Wei-Ling Zhang; Yi-Zhuo Wang; Yi Zhang; You Yi; Fan Li; Tian Zhi; Dong-Sheng Huang
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.